Functional Diversity of Heat-labile Toxins (LT) Produced by Enterotoxigenic Escherichia coli
暂无分享,去创建一个
J. H. Amorim | M. E. Sbrogio-Almeida | L. Ferreira | J. Rodrigues | C. Mathias-Santos | A. Balan | J. Cabrera-Crespo | J. F. Rodrigues | Camila Mathias-Santos
[1] R. Rappuoli,et al. Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin , 2009, PloS one.
[2] Weiping Zhang,et al. Escherichia coli Constructs Expressing Human or Porcine Enterotoxins Induce Identical Diarrheal Diseases in a Piglet Infection Model , 2008, Applied and Environmental Microbiology.
[3] M. E. Sbrogio-Almeida,et al. Cytotoxic T cell adjuvant effects of three Salmonella enterica flagellins , 2008, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
[4] M. E. Sbrogio-Almeida,et al. Genetic Diversity of Heat-Labile Toxin Expressed by Enterotoxigenic Escherichia coli Strains Isolated from Humans , 2008, Journal of bacteriology.
[5] R. Moxley,et al. Significance of Heat-Stable and Heat-Labile Enterotoxins in Porcine Colibacillosis in an Additive Model for Pathogenicity Studies , 2006, Infection and Immunity.
[6] Gerrit Groenhof,et al. GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..
[7] T. D. Connell,et al. Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections , 2005, Journal of dental research.
[8] J. Mcghee,et al. Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract , 2005, Infection and Immunity.
[9] T. D. Connell,et al. Differential Binding of Escherichia coli Enterotoxins LT-IIa and LT-IIb and of Cholera Toxin Elicits Differences in Apoptosis, Proliferation, and Activation of Lymphoid Cells , 2005, Infection and Immunity.
[10] K Henrick,et al. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. , 2004, Acta crystallographica. Section D, Biological crystallography.
[11] Lolke de Haan,et al. Cholera toxin: A paradigm for multi-functional engagement of cellular mechanisms (Review) , 2004, Molecular membrane biology.
[12] C. Czerkinsky,et al. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. , 2003, Vaccine.
[13] H. Bone,et al. Mutant Escherichia coli Heat-Labile Toxin B Subunit That Separates Toxoid-Mediated Signaling and Immunomodulatory Action from Trafficking and Delivery Functions , 2003, Infection and Immunity.
[14] H. Schweizer. Vectors to express foreign genes and techniques to monitor gene expression in Pseudomonads. , 2001, Current opinion in biotechnology.
[15] G. Dougan,et al. Immunomodulation Using Bacterial Enterotoxins , 2001, Scandinavian journal of immunology.
[16] T. Sata,et al. Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain. , 2001, Vaccine.
[17] E. Ruby,et al. Vibrio fischeri Genes hvnA andhvnB Encode Secreted NAD+-Glycohydrolases , 2001, Journal of bacteriology.
[18] R. Rappuoli,et al. Modulation of Innate and Acquired Immune Responses by Escherichia coli Heat-Labile Toxin: Distinct Pro- and Anti-Inflammatory Effects of the Nontoxic AB Complex and the Enzyme Activity1 , 2000, The Journal of Immunology.
[19] G. Dougan,et al. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants. , 1999, Journal of immunology.
[20] R. Rappuoli,et al. Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides. , 1999, Immunology letters.
[21] W. Hol,et al. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat‐labile enterotoxin and its B subunit , 1998, Immunology.
[22] J. Wilschut,et al. The role of ADP‐ribosylation and GM1‐binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat‐labile enterotoxin and Vibrio cholerae cholera toxin , 1998, Immunology and cell biology.
[23] G. Dougan,et al. Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity , 1998, The Journal of experimental medicine.
[24] James P. Nataro,et al. Diarrheagenic Escherichia coli , 1998, Clinical Microbiology Reviews.
[25] Berk Hess,et al. LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..
[26] R. Lechler,et al. Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. , 1997, Gene.
[27] J. Kaper,et al. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. , 1996, Microbiological reviews.
[28] T. Hirst,et al. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] W. Hol,et al. The Arg7Lys mutant of heat-labile enterotoxin exhibits great flexibility of active site loop 47-56 of the A subunit. , 1995, Biochemistry.
[30] J. Clements,et al. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity , 1995, Infection and immunity.
[31] R. Rappuoli,et al. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit , 1994, The Journal of experimental medicine.
[32] R. Rappuoli,et al. Common features of the NAD‐binding and catalytic site of ADP‐ribosylating toxins , 1994, Molecular microbiology.
[33] R. Rappuoli,et al. Probing the structure‐activity relationship of Escherichia coli LT‐A by site‐directed mutagenesis , 1994, Molecular microbiology.
[34] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[35] D S Moss,et al. Main-chain bond lengths and bond angles in protein structures. , 1993, Journal of molecular biology.
[36] T. Sixma,et al. Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. , 1993, Journal of molecular biology.
[37] T. Sixma,et al. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli , 1991, Nature.
[38] M. Petric,et al. Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin , 1985, Journal of clinical microbiology.
[39] W. Dallas,et al. Nucleotide sequence comparison between heat-labile toxin B-subunit cistrons from Escherichia coli of human and porcine origin , 1985, Infection and immunity.
[40] T. Yamamoto,et al. Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans. , 1984, The Journal of biological chemistry.
[41] Y. Takeda,et al. Molecular heterogeneity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli , 1982, Infection and immunity.
[42] Y. Takeda,et al. Immunological nonidentity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli , 1981, Infection and immunity.
[43] D. A. Yost,et al. Purification and properties of the soluble NAD glycohydrolase from Bungarus fasciatus venom. , 1981, The Journal of biological chemistry.
[44] J. Holmgren,et al. Evaluation of a ganglioside immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin , 1979, Journal of clinical microbiology.
[45] J. Mekalanos,et al. Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants , 1978, Infection and immunity.
[46] R. Collier,et al. Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa , 1977, Infection and immunity.
[47] L. Ferreira,et al. Functional and immunological characterization of a natural polymorphic variant of a heat-labile toxin (LT-I) produced by enterotoxigenic Escherichia coli (ETEC). , 2009, FEMS immunology and medical microbiology.
[48] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[49] D. Ladant,et al. The comprehensive sourcebook of bacterial protein toxins , 1999 .
[50] B. Mackler. [49] DPNH oxidase of heart muscle , 1967 .